| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership | 
|---|---|---|---|---|---|---|---|
| ProPhase Labs, Inc. | Director | Option (right to buy) | 500K | Jan 1, 2024 | Direct | 
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role | 
|---|---|---|---|---|---|---|---|
| WINT | WINDTREE THERAPEUTICS INC /DE/ | Aug 13, 2024 | 0 | $0 | 3 | Aug 14, 2024 | Director | 
| PRPH | ProPhase Labs, Inc. | Jan 1, 2024 | 1 | $0 | 4 | Mar 19, 2024 | Director | 
| PRPH | ProPhase Labs, Inc. | Jan 1, 2024 | 0 | $0 | 3 | Mar 19, 2024 | Chief Operating Officer |